Salta alla navigazione principale
Salta alla ricerca
Salta al contenuto principale
Università del Piemonte Orientale Home
Italiano
English
Home
Profili
Unità di ricerca
Apparecchiatura
Progetti
Risultato della ricerca
Ricerca per competenza, nome o affiliazione
Survivin gene expression in chronic liver disease and hepatocellular carcinoma
M. Montorsi
, M. Maggioni
, M. Falleni
, C. Pellegrini
,
Matteo Davide DONADON
, G. Torzilli
, R. Santambrogio
, A. Spinelli
, G. Coggi
, S. Bosari
Dipartimento di Scienze della Salute
Risultato della ricerca
:
Contributo su rivista
›
Articolo in rivista
›
peer review
Panoramica
Fingerprint
Fingerprint
Entra nei temi di ricerca di 'Survivin gene expression in chronic liver disease and hepatocellular carcinoma'. Insieme formano una fingerprint unica.
Ordina per
Peso
Alfabetico
Keyphrases
Hepatocellular Carcinoma
100%
Gene Expression
100%
Chronic Liver Disease
100%
Survivin
100%
Survivin Gene
100%
Liver Tissue
57%
Non-neoplastic
42%
Survivin mRNA
42%
Cell Cycle Regulation
14%
Clinical Significance
14%
Cell Death
14%
Diagnostic Significance
14%
Lung Cancer
14%
Prognostic Significance
14%
Statistical Significance
14%
MRNA Level
14%
Microvascular Invasion
14%
Aggressive Tumor
14%
Tumor Recurrence
14%
Liver Cancer
14%
Cell-to-cell
14%
Real-time RT-PCR
14%
Colon Cancer
14%
Human Malignancies
14%
Tumor Features
14%
Tumor Grade
14%
Surgical Patients
14%
Survivin Expression
14%
Activity Score
14%
Oncofetal Antigen
14%
Differentiated Tissues
14%
Medicine and Dentistry
Chronic Liver Disease
100%
Hepatocellular Carcinoma
100%
Gene Expression
100%
Survivin
100%
Liver Tissue
33%
Messenger RNA
25%
Neoplasm
16%
Cell Death
8%
Colon Carcinoma
8%
Cancer
8%
Tumor Recurrence
8%
Lung Cancer
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Liver Cancer
8%
Clinical Significance
8%
Cell Cycle Regulation
8%
Oncofetal Antigen
8%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Chronic Liver Disease
100%
Survivin
100%
Messenger RNA
25%
Neoplasm
16%
Lung Cancer
8%
Colon Carcinoma
8%
Tumor Recurrence
8%
Liver Cancer
8%
Oncofetal Antigen
8%